Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers

NCT01005797 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Renal Cancer
Non Small Cell Lung Cancer (NSCLC)
Soft Tissue Sarcoma

Interventions

DRUG: Panobinostat (LBH589), Sorafenib

Sponsor

Medical University of South Carolina

Collaborators

[object Object]